Article PDF
References
American College of Physicians, 1992 Guidelines for counseling postmenopausal women about preventive hormone therapy. Ann Intern Med 117: 1038–1042.
Hulley S, Grady D, Bush T, et al, 1998 Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 280: 605–613.
Writing Group for the Women’s Health Initiative Investigators, 2002 Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women. JAMA 288: 321–333.
Notelovitz M, Lenihan JP, McDermott M, et al, 2000 Initial 17beta-estradiol dose for treating vasomotor symptoms. Obstet Gynecol 95: 726–731.
Ettinger B, Genant HK, Steiger P, Madvig P, 1992 Low-dosage micronized 17 beta-estradiol prevents bone loss in postmenopausal women. Am J Obstet Gynecol 166: 479–488.
Grodstein F, Manson JE, Stampfer MJ, Rexrode K, 2008 Postmenopausal hormone therapy and stroke: role of time since menopause and age at initiation of hormone therapy. Arch Intern Med 168: 861–866.
Pines A, Sturdee DW, Birkhauser M, et al, 2007 IMS updated recommendations on postmenopausal hormone therapy. Climacteric 10: 181–194.
Pines A, Sturdee DW, Birkhauser M, et al, 2008 Summary of the first IMS Global Summit on menopause-related issues: HRT in the early postmenopause. Climacteric 11: 267–272.
Rossouw JE, Prentice RL, Manson JE, et al, 2007 Post-menopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 297: 1465–1477.
Grodstein F, Manson JE, Stampfer MJ, 2006 Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation. J Womens Health 15: 35–44.
Salpeter SR, Walsh JM, Greyber E, Salpeter EE, 2006 Brief report: Coronary heart disease events associated with hormone therapy in younger and older women. A meta-analysis. J Gen Intern Med 21: 363–366.
Hsia J, Langer RD, Manson JE, et al, 2006 Conjugated equine estrogens and coronary heart disease: the Women’s Health Initiative. Arch Intern Med 166: 357–365.
Saltiki K, Alevizaki M, 2007 Coronary heart disease in postmenopausal women; the role of endogenous estrogens and their receptors. Hormones (Athens) 6: 9–24.
Manson JE, Allison MA, Rossouw JE, et al, 2007 Estrogen therapy and coronary-artery calcification. NEJM; 356: 2591–2602.
Margolis KL, Bonds DE, Rodabough RJ, et al, 2004 Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women’s Health Initiative Hormone Trial. Diabetologia 47: 1175–1187.
Pentti K, Tuppurainen MT, Honkanen R, et al, 2009 Hormone therapy protects from diabetes: the Kuopio Osteoporosis Risk Factor and Prevention Study. Eur J Endocrinol preprint on-line 25 March 2009.
Hendrix SL, Wassertheil-Smoller S, Johnson KC, et al, 2006 Effects of conjugated equine estrogen on stroke in the Women’s Health Initiative. Circulation 113: 2425–2434.
Anderson GL, Limacher M, Assaf AR, et al, 2004 Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s Health Initiative randomized controlled trial. JAMA 291: 1701–1712.
Cushman M, Kuller LH, Prentice R, et al, 2004 Estrogen plus progestin and risk of venous thrombosis. JAMA 292: 1573–1580.
Canonico M, Plu-Bureau G, Lowe GD, Scarabin PY, 2008 Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis. BMJ 336: 1227–1231.
Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer, 1997 Collaborative Group on Hormonal Factors in Breast Cancer. 350: 1047–1059.
Chlebowski RT, Hendrix SL, Langer RD, et al, 2003 Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women’s Health Initiative Randomized Trial. JAMA 289: 3243–3253.
Stefanick ML, Anderson GL, Margolis KL, et al, 2006 Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy. JAMA 295: 1647–1657.
Chlebowski RT, Kuller LH, Prentice RL, et al, 2009 Breast cancer after use of estrogen plus progestin in postmenopausal women. N Engl J Med 360: 573–587.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pines, A. Where postmenopausal hormone therapy stands today. Hormones 8, 227–231 (2009). https://doi.org/10.14310/horm.2002.1241
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.14310/horm.2002.1241